U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
114271114271Europain®: A Study of Procedural PainCompletedNo Results AvailablePainhttps://ClinicalTrials.gov/show/NCT01070082
114272114272Percutaneous Endovascular Aneurysm Repair (PEVAR) TrialCompletedNo Results AvailableAbdominal Aortic AneurysmDevice: PEVAR (ProGlide closure)|Device: SEVAR (IntuiTrak)|Device: PEVAR (Prostar XL closure)https://ClinicalTrials.gov/show/NCT01070069
114273114273Practice-based Trial of Blood Pressure Control in African AmericansCompletedNo Results AvailableHypertension|Physical Activity|Diet|Medication AdherenceBehavioral: Therapeutic Lifestyle Changes (MINT-TLC)|Behavioral: Usual Carehttps://ClinicalTrials.gov/show/NCT01070056
114274114274To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan AloneCompletedHas ResultsHypertension|High Blood PressureDrug: Amlodipine 5mg/Valsartan 80 mg|Drug: Valsartanhttps://ClinicalTrials.gov/show/NCT01070043
114275114275Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II HypertensionCompletedNo Results AvailableStage II HypertensionDrug: Aliskiren/Amlodipine (150/5 mg/day, 300/10 mg/day) , Aliskiren/Amlodipine/Hydrochlorothiazide (300/10/12.5 mg/day, 300/10/25 mg/day)https://ClinicalTrials.gov/show/NCT01070030
114276114276Community-based Accompaniment With Supervised Antiretrovirals in Lima, PeruActive, not recruitingNo Results AvailableHIV|AIDS|HIV InfectionsOther: DOT-HAARThttps://ClinicalTrials.gov/show/NCT01070017
114277114277Effect of Countermeasures on Nocturnal Driving PerformanceCompletedNo Results AvailableSleepinessOther: Real driving situation|Other: Driving simulatorhttps://ClinicalTrials.gov/show/NCT01070004
114278114278Asthma Self-Management For AdolescentsCompletedNo Results AvailableAsthmaBehavioral: Patient education group|Behavioral: Wait list control grouphttps://ClinicalTrials.gov/show/NCT01069991
114279114279Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes MellitusTerminatedNo Results AvailableDiabetes MellitusDrug: BGP-15 100 mg QD|Drug: BGP-15 100 mg BID|Drug: Placebo BID|Drug: BGP-15 200 mg QD|Drug: BGP-15 200 mg BID|Drug: BGP-15 400 mg QDhttps://ClinicalTrials.gov/show/NCT01069965
114280114280Electrical Stimulation of the Internal Capsule for Intractable DepressionCompletedNo Results AvailableDepressionDevice: Deep Brain Stimulation Systemhttps://ClinicalTrials.gov/show/NCT01069952
114281114281Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose AspirinCompletedHas ResultsPreventionDrug: Esomeprazole|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01069939
114282114282To Assess the Pharmacokinetics of AZD1656 and Its Metabolite in Type 2 Diabetes Mellitus PatientsCompletedNo Results AvailableGlucose LoweringDrug: AZD1656https://ClinicalTrials.gov/show/NCT01069926
114283114283Pharmacokinetics Profile Study of BG00012 Standard Formulation and BG00012 Active Pharmaceutical IngredientCompletedNo Results AvailableHealthyDrug: BG00012https://ClinicalTrials.gov/show/NCT01069913
114284114284Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal InfectionCompletedNo Results AvailableIntraabdominal InfectionsDrug: Moxifloxacin (Avelox, BAY12-8039)|Drug: Ertapenem|Drug: Clavulanate|Drug: Amoxicillinhttps://ClinicalTrials.gov/show/NCT01069900
114285114285A Prospective Registry for Febrile Events in Patients With Malignant Hemopathies or Subjected to Haematopoietic Stem Cell TransplantCompletedNo Results AvailableHematological Malignancies|Stem Cell Transplantationhttps://ClinicalTrials.gov/show/NCT01069887
114286114286Trial of Vitamin D Supplementation for the Prevention of Influenza and Other Respiratory Infections (ViDiFlu)CompletedNo Results AvailableRespiratory Tract Infections|InfluenzaDietary Supplement: Cholecalciferol (Vitamin D/Vigantol oil)|Dietary Supplement: Miglyol oilhttps://ClinicalTrials.gov/show/NCT01069874
114287114287Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN)TerminatedHas ResultsPPHN|Persistent Pulmonary Hypertension of the Newborn|Hypoxic Respiratory FailureDrug: sildanefilhttps://ClinicalTrials.gov/show/NCT01069861
114288114288[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT01069848
114289114289Epidemiological Study to Describe Non Small Cell Lung Cancer (NSCLC) Clinical Management Patterns in Central Eastern Europe and Russia (Lung-EPICLIN)CompletedNo Results AvailableNon Small Cell Lung Cancerhttps://ClinicalTrials.gov/show/NCT01069835
114290114290A Study in Healthy Volunteers to Assess Effect of AZD6765 on Midazolam Blood LevelsCompletedNo Results AvailableHealthyDrug: AZD6765|Drug: midazolamhttps://ClinicalTrials.gov/show/NCT01069822
114291114291Safety and Efficacy Study of AGS-004 During Analytical Treatment InterruptionActive, not recruitingNo Results AvailableHIV InfectionBiological: AGS-004|Biological: Placebohttps://ClinicalTrials.gov/show/NCT01069809
114292114292Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast CancerTerminatedNo Results AvailableTriple Negative Metastatic Breast CancerDrug: Paclitaxel|Drug: Bevacizumab|Drug: Capecitabinehttps://ClinicalTrials.gov/show/NCT01069796
114293114293Study of A3309 in Patients With DyslipidemiaCompletedNo Results AvailableDyslipidemiaDrug: A3309|Drug: A3309|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01069783
114294114294Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC)RecruitingNo Results AvailableClear Cell Renal Cell Carcinoma|MetastasisDrug: Sunitinibhttps://ClinicalTrials.gov/show/NCT01069770
114295114295A Study of ARQ 197 in Combination With ErlotinibCompletedNo Results AvailableNon-small-cell Lung CancerDrug: ARQ 197 and Erlotinibhttps://ClinicalTrials.gov/show/NCT01069757
114296114296Oral Entrainment on Suck Development of Preterm Infants Born 23 to 34 Weeks Gestational Age (GA)CompletedNo Results AvailablePreterm Birthhttps://ClinicalTrials.gov/show/NCT01069744
114297114297Comparison of Non-nutritive Suck (NNS) Measures to Clinical Estimates of Suck and Feeding Readiness in Preterm InfantsCompletedNo Results AvailablePreterm Birthhttps://ClinicalTrials.gov/show/NCT01069731
114298114298Evaluating Patterned Oral Somatosensory Entrainment Stimulation Using the NTrainer on Oral Feeding PerformanceCompletedNo Results AvailablePreterm Birthhttps://ClinicalTrials.gov/show/NCT01069718
114299114299Second Open Label Extension to Bridging Study CTBM100C2303CompletedNo Results AvailablePulmonary Infections|Pseudomonas AeruginosaDrug: Tobramycin inhalation powderhttps://ClinicalTrials.gov/show/NCT01069705
114300114300Placebo Versus SBR759 in Lowering Phosphate in Dialysis PatientsCompletedNo Results AvailableHyperphosphatemia|Chronic Kidney DiseaseDrug: SBR759A|Drug: SBR759A|Drug: SBR759A|Drug: SBR759A|Drug: SBR759Ahttps://ClinicalTrials.gov/show/NCT01069692

* Görseller ve İçerik tekif hakkına sahip olabilir